On March 20, 2018, David Schlachet informed BioTime, Inc. during a regularly scheduled quarterly Board of Directors meeting that, for personal reasons he has decided to not stand for reelection as a director at 2018 annual meeting of shareholders. Mr. Schlachet’s decision was influenced by the logistics of serving as a director while residing in Israel. However, Mr. Schlachet remains committed to BioTime and will continue to serve as a director of Cell Cure Neurosciences Ltd., a subsidiary of BioTime, located in Jerusalem, Israel.